Publisher: Wiley-Blackwell

Related content
Volume 14, Number 1, 1 January 2013

< previous issue | all issues | next issue >

Favourites:Add to Favourites

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality
pp. 10-20(11)
Authors: Klein, MB; Rollet, KC; Saeed, S; Cox, J; Potter, M; Cohen, J; Conway, B; Cooper, C; Côté, P; Gill, J; Haase, D; Haider, S; Hull, M; Moodie, E; Montaner, J; Pick, N; Rachlis, A; Rouleau, D; Sandre, R; Tyndall, M; Walmsley, S; Canadian HIV‐HCV Cohort Investigatorshiv1028-cr-0022; Cohen, Jeff; Conway, Brian; Cooper, Curtis; Côté, Pierre; Cox, Joseph; Gill, John; Tyndall, Mark; Haider, Shariq; Harris, Marrianne; Hasae, David; Montaner, Julio; Moodie, Erica; Pick, Neora; Rachlis, Anita; Sandre, Roger; Rouleau, Danielle; Wong, David; Hull, Mark; Walmsley, Sharon

Favourites:Add to Favourites

Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital
pp. 21-30(10)
Authors: Riveiro‐Barciela, M; Falcó, V; Burgos, J; Curran, A; Van den Eynde, E; Navarro, J; Villar del Saz, S; Ocaña, I; Ribera, E; Crespo, M; Pahissa, A

Favourites:Add to Favourites

Induced first abortion rates before and after HIV diagnosis: results of an Italian self‐administered questionnaire survey carried out in 585 women living with HIV
pp. 31-39(9)
Authors: Ammassari, A; Cicconi, P; Ladisa, N; Sora, F; Bini, T; Trotta, MP; D'Ettorre, G; Cattelan, AM; Vichi, F; d'Arminio Monforte, A; the DiDi Study Grouphiv1032-cr-0011

Favourites:Add to Favourites

Differences between HIV‐infected and uninfected adults in the contributions of smoking, diabetes and hypertension to acute coronary syndrome: two parallel case–control studies
pp. 40-48(9)
Authors: Calvo‐Sánchez, M; Perelló, R; Pérez, I; Mateo, MG; Junyent, M; Laguno, M; Blanco, JL; Martínez‐Rebollar, M; Sánchez, M; Mallolas, J; Gatell, JM; Domingo, P; Martínez, E

Favourites:Add to Favourites

Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naïve patients in the ARTEMIS trial
pp. 49-59(11)
Authors: Orkin, C; DeJesus, E; Khanlou, H; Stoehr, A; Supparatpinyo, K; Lathouwers, E; Lefebvre, E; Opsomer, M; Van de Casteele, T; Tomaka, F

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more